We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




DNA Could Become Foundation of Next-Generation Logic Chips

By LabMedica International staff writers
Posted on 10 Jun 2010
In a single day, a solitary graduate student at a lab bench has shown he can generate more simple logic circuits than the world's entire output of silicon chips in one month. More...


A Duke University (Durham, NC, USA) engineer believes that the next generation of these logic circuits at the basis of computers will be produced inexpensively in nearly limitless quantities. The secret is that instead of silicon chips serving as the platform for electric circuits, computer engineers will take advantage of the unique properties of DNA, that double-helix carrier of all life's information.

In his latest set of experiments, Dr. Chris Dwyer, assistant professor of electrical and computer engineering at Duke's Pratt School of Engineering, demonstrated that by simply mixing modified bits of DNA and other molecules, he could create literally billions of identical, tiny, waffle-looking structures. Dr. Dwyer has demonstrated that these nanostructures will efficiently self-assemble, and when different light-sensitive molecules are added to the mixture, the waffles exhibit unique and "programmable” characteristics that can be readily utilized. Using light to excite these molecules, known as chromophores, he can create simple logic gates, or switches.

These nanostructures can then be used as the building blocks for a host of applications, ranging from the biomedical to the computational. "When light is shined on the chromophores, they absorb it, exciting the electrons,” Dr. Dwyer stated. "The energy released passes to a different type of chromophore nearby that absorbs the energy and then emits light of a different wavelength. That difference means this output light can be easily differentiated from the input light, using a detector.”

Instead of conventional circuits using electrical current to rapidly switch between zeros or ones, or to yes and no, light can be used to stimulate similar responses from the DNA-based switches--and much faster.

"This is the first demonstration of such an active and rapid processing and sensing capacity at the molecular level,” Dr. Dwyer said. The findings of his experiments were published online in May 2010 in the journal Small. "Conventional technology has reached its physical limits. The ability to cheaply produce virtually unlimited supplies of these tiny circuits seems to me to be the next logical step.”

DNA is a well-understood molecule comprised of pairs of complimentary nucleotide bases that have an affinity for each other. Customized snippets of DNA can inexpensively be synthesized by positioning the pairs in any order. In their experiments, the researchers took advantage of DNA's natural ability to fasten onto corresponding and specific areas of other DNA snippets.

Dr. Dwyer used a jigsaw puzzle analogy to describe the process of what occurs when all the waffle ingredients are mixed together in a container. "It's like taking pieces of a puzzle, throwing them in a box and as you shake the box, the pieces gradually find their neighbors to form the puzzle,” he said. "What we did was to take billions of these puzzle pieces, throwing them together, to form billions of copies of the same puzzle.”

In the current experiments, the waffle puzzle had 16 pieces, with the chromophores located atop the waffle's ridges. More complicated circuits can be created by building structures composed of many of these small components, or by building larger waffles. The possibilities are limitless, according to Dr. Dwyer.

In addition to their use in computing, Dr. Dwyer noted that since these nanostructures are basically sensors, many biomedical applications are possible. Tiny nanostructures could be constructed that could respond to different proteins that are markers for disease in a single drop of blood.

Related Links:
Duke University




Gold Member
Veterinary Hematology Analyzer
Exigo H400
Serological Pipet Controller
PIPETBOY GENIUS
New
Modular Hemostasis Automation Solution
CN Track
New
Silver Member
Autoimmune Hepatitis Test
LKM-1-Ab ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: New research brings hope for improved early detection of pancreatic cancer (Photo courtesy of Adobe Stock)

New Biomarker Panel to Enable Early Detection of Pancreatic Cancer

Pancreatic cancer (PC) has one of the worst prognoses globally, with only 13% of diagnosed patients surviving for five years or more. In Ireland, there are about 900 cases of pancreatic cancer annually,... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.